| Medical and Health Sciences | Lifetime | 335 | SE 6 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 43 | SE 1 | 99.96 |
| Surgery | Lifetime | 628 | SE 13 | 99.41 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 631 | SE 11 | 97.95 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 835 | SE 12 | 97.75 |
| Internal Medicine | Lifetime | 120 | SE 3 | 97.38 |
| Rheumatology | Lifetime | 775 | SE 18 | 96.02 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 209 | SE 5 | 98.54 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 15 | SE 1 | 99.94 |
| GDF15 and Related Biomarkers | Lifetime | 1 | SE 1 | 99.61 |
| Acute Myocardial Infarction Research | Lifetime | 15 | SE 1 | 99.95 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 12 | SE 1 | 99.92 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 47 | SE 1 | 99.79 |
| Cardiac Imaging and Diagnostics | Lifetime | 146 | SE 1 | 99.73 |
| Coronary Interventions and Diagnostics | Lifetime | 131 | SE 2 | 99.58 |
| Heart Failure Treatment and Management | Lifetime | 130 | SE 4 | 99.48 |
| Lipoproteins and Cardiovascular Health | Lifetime | 118 | SE 2 | 99.36 |
| Cardiac Arrhythmias and Treatments | Lifetime | 209 | SE 3 | 99.36 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 463 | SE 5 | 98.81 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 488 | SE 17 | 98.40 |
| Cholesterol and Lipid Metabolism | Lifetime | 272 | SE 8 | 97.15 |
| Hormonal and reproductive studies | Lifetime | 639 | SE 25 | 97.08 |
| Nutrition and Health in Aging | Lifetime | 963 | SE 31 | 96.94 |
| Cancer, Lipids, and Metabolism | Lifetime | 997 | SE 24 | 96.60 |
| Macrophage Migration Inhibitory Factor | Lifetime | 194 | SE 5 | 93.53 |
| Cardiac Fibrosis and Remodeling | Lifetime | 628 | SE 3 | 92.60 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 708 | SE 16 | 88.75 |
| Synthesis of β-Lactam Compounds | Lifetime | 824 | SE 3 | 82.55 |
| GDF15 and Related Biomarkers | 2021-2025 | 12 | SE 1 | 94.58 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 281 | SE 3 | 98.03 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 34 | SE 1 | 94.05 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 535 | SE 8 | 89.18 |
| S100 Proteins and Annexins | 2021-2025 | 944 | SE 47 | 59.79 |
| Apelin-related biomedical research | 2021-2025 | 601 | SE 3 | 42.80 |
